SPDR SERIES TRUST (XPH)
Verwaltungsgesellschaft · ARCX · Serie S000012321 · Auf SEC EDGAR ansehen ↗
Bestandsdaten sind für diesen Fonds noch nicht verfügbar.
Auf dieser Seite
- Fondstransaktionen Geld, das jeden Monat in den Fonds fließt und aus ihm abfließt, aus N-PORT-Einreichungen.
- Bestände Jede Position, die der Fonds derzeit hält, mit Gewichtungen.
- Institutionelle Eigentümer 13F-Institutionen, die angeben, diesen ETF zu halten.
- Ähnliche Fonds Andere Fonds mit überlappenden Beständen oder vergleichbarer Größe.
Fondsflüsse (SEC-gemeldet)
- Letzter Monat (Mär 2026)
- -$31K
- Quartalsende Mär 2026
- +$89.8M
- Letzte 12 Monate
- +$111.4M
Apr 2025 – Mär 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Vollständige Zusammensetzung 62 Beteiligungen
| Name | CUSIP | Wert | % | Bilanz | Kategorie | Land |
|---|---|---|---|---|---|---|
| State Street Global Advisors | 857492706 | $24.4M | 7,93 | 24.400.789 | STIV | US |
| Enliven Therapeutics Inc | 29337E102 | $7.5M | 2,45 | 192.297 | EC | US |
| Corcept Therapeutics Inc | 218352102 | $7.1M | 2,29 | 174.971 | EC | US |
| Terns Pharmaceuticals Inc | 880881107 | $6.7M | 2,16 | 126.197 | EC | US |
| Perrigo Co PLC | — | $6.5M | 2,10 | 601.785 | EC | IE |
| Axsome Therapeutics Inc | 05464T104 | $6.3M | 2,03 | 37.013 | EC | US |
| Innoviva Inc | 45781M101 | $6.1M | 1,99 | 263.314 | EC | US |
| Merck & Co Inc | 58933Y105 | $6.1M | 1,98 | 50.800 | EC | US |
| Pfizer Inc | 717081103 | $6.1M | 1,97 | 216.247 | EC | US |
| Royalty Pharma PLC | — | $6.1M | 1,97 | 126.441 | EC | GB |
| Elanco Animal Health Inc | 28414H103 | $6.0M | 1,96 | 251.749 | EC | US |
| Jazz Pharmaceuticals PLC | — | $6.0M | 1,96 | 31.838 | EC | IE |
| Esperion Therapeutics Inc | 29664W105 | $6.0M | 1,95 | 2.194.800 | EC | US |
| Edgewise Therapeutics Inc | 28036F105 | $6.0M | 1,95 | 190.497 | EC | US |
| MBX Biosciences Inc | 55287L101 | $6.0M | 1,95 | 200.744 | EC | US |
| Definium Therapeutics Inc | 24477V105 | $6.0M | 1,95 | 316.882 | EC | CA |
| Bristol-Myers Squibb Co | 110122108 | $6.0M | 1,94 | 98.425 | EC | US |
| ANI Pharmaceuticals Inc | 00182C103 | $6.0M | 1,93 | 77.382 | EC | US |
| Johnson & Johnson | 478160104 | $5.9M | 1,93 | 24.295 | EC | US |
| Tarsus Pharmaceuticals Inc | 87650L103 | $5.9M | 1,92 | 84.481 | EC | US |
| Trevi Therapeutics Inc | 89532M101 | $5.9M | 1,92 | 494.432 | EC | US |
| Pacira BioSciences Inc | 695127100 | $5.8M | 1,90 | 258.586 | EC | US |
| Zoetis Inc | 98978V103 | $5.8M | 1,89 | 49.282 | EC | US |
| Crinetics Pharmaceuticals Inc | 22663K107 | $5.8M | 1,88 | 159.642 | EC | US |
| Nektar Therapeutics | 640268306 | $5.8M | 1,88 | 80.506 | EC | US |
| Liquidia Corp | 53635D202 | $5.8M | 1,88 | 153.099 | EC | US |
| Amneal Pharmaceuticals Inc | 03168L105 | $5.8M | 1,88 | 464.477 | EC | US |
| Harmony Biosciences Holdings Inc | 413197104 | $5.7M | 1,87 | 205.054 | EC | US |
| Supernus Pharmaceuticals Inc | 868459108 | $5.7M | 1,86 | 110.926 | EC | US |
| Viatris Inc | 92556V106 | $5.7M | 1,85 | 422.585 | EC | US |
| Xeris Biopharma Holdings Inc | 98422E103 | $5.7M | 1,84 | 975.649 | EC | US |
| Harrow Inc | 415858109 | $5.6M | 1,83 | 159.813 | EC | US |
| Organon & Co | 68622V106 | $5.5M | 1,79 | 922.423 | EC | US |
| Nuvation Bio Inc | 67080N101 | $5.5M | 1,79 | 1.286.168 | EC | US |
| Phibro Animal Health Corp | 71742Q106 | $5.5M | 1,79 | 99.625 | EC | US |
| Amylyx Pharmaceuticals Inc | 03237H101 | $5.5M | 1,79 | 395.413 | EC | US |
| Indivior Pharmaceuticals Inc | 45579U109 | $5.5M | 1,78 | 179.821 | EC | US |
| Collegium Pharmaceutical Inc | 19459J104 | $5.5M | 1,78 | 165.736 | EC | US |
| Eli Lilly & Co | 532457108 | $5.4M | 1,76 | 5.904 | EC | US |
| Prestige Consumer Healthcare Inc | 74112D101 | $5.4M | 1,75 | 91.089 | EC | US |
| Ligand Pharmaceuticals Inc | 53220K504 | $5.3M | 1,73 | 26.684 | EC | US |
| Ocular Therapeutix Inc | 67576A100 | $5.3M | 1,71 | 621.423 | EC | US |
| Omeros Corp | 682143102 | $5.2M | 1,70 | 494.846 | EC | US |
| EyePoint Inc | 30233G209 | $5.1M | 1,66 | 395.677 | EC | US |
| Alumis Inc | 022307102 | $4.9M | 1,60 | 224.127 | EC | US |
| Amphastar Pharmaceuticals Inc | 03209R103 | $4.5M | 1,45 | 227.681 | EC | US |
| Phathom Pharmaceuticals Inc | 71722W107 | $4.4M | 1,44 | 398.901 | EC | US |
| Theravance Biopharma Inc | — | $4.4M | 1,42 | 268.815 | EC | KY |
| Rapport Therapeutics Inc | 75383L102 | $4.2M | 1,37 | 134.504 | EC | US |
| Arvinas Inc | 04335A105 | $3.8M | 1,25 | 362.073 | EC | US |
Seite 1
von 2
← Zurück
Weiter →
Institutionelle Eigentümer (13F) 103 Einreicher
Institutionen, die diese ETF in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann zweimal für separate Optionskontrakte erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Institution | Wert | % der verfolgten 13F | Aktien | Typ | Stand |
|---|---|---|---|---|---|
| CWM, LLC | $39.299.337 | 21,84% | 726.555 | Aktien | 31. März 2026 |
| WELLS FARGO & COMPANY/MN | $16.567.500 | 9,21% | 250.000 | Aktien | 30. Juni 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $14.700.142 | 8,17% | 221.822 | Aktien | 30. Juni 2026 |
| FIRST CITIZENS BANK & TRUST CO | $12.896.142 | 7,17% | 194.600 | Aktien | 30. Juni 2026 |
| Envestnet Portfolio Solutions, Inc. | $11.963.127 | 6,65% | 180.521 | Aktien | 30. Juni 2026 |
| LPL Financial LLC | $11.161.122 | 6,20% | 168.419 | Aktien | 30. Juni 2026 |
| CITIGROUP INC | $6.899.635 | 3,83% | 104.114 | Aktien | 30. Juni 2026 |
| TRUIST FINANCIAL CORP | $4.683.863 | 2,60% | 70.678 | Aktien | 30. Juni 2026 |
| Measured Wealth Private Client Group, LLC | $4.526.639 | 2,52% | 68.306 | Aktien | 30. Juni 2026 |
| Private Advisor Group, LLC | $4.221.174 | 2,35% | 63.697 | Aktien | 30. Juni 2026 |
| Kingsview Wealth Management, LLC | $3.803.284 | 2,11% | 70.314 | Aktien | 31. März 2026 |
| Cetera Investment Advisers | $3.247.485 | 1,81% | 49.004 | Aktien | 30. Juni 2026 |
| Wharton Business Group, LLC | $3.074.597 | 1,71% | 46.395 | Aktien | 30. Juni 2026 |
| BANK OF AMERICA CORP /DE/ | $2.901.963 | 1,61% | 43.790 | Aktien | 30. Juni 2026 |
| UBS Group AG | $2.659.017 | 1,48% | 40.124 | Aktien | 30. Juni 2026 |
| TWO SIGMA INVESTMENTS, LP | $2.369.219 | 1,32% | 35.751 | Aktien | 30. Juni 2026 |
| Clark Capital Management Group, Inc. | $2.182.205 | 1,21% | 32.929 | Aktien | 30. Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.121.435 | 1,18% | 32.012 | Aktien | 30. Juni 2026 |
| Baird Financial Group, Inc. | $1.886.574 | 1,05% | 28.468 | Aktien | 30. Juni 2026 |
| MAI Capital Management | $1.850.193 | 1,03% | 27.919 | Aktien | 30. Juni 2026 |
| GTS SECURITIES LLC | $1.781.669 | 0,99% | 26.885 | Aktien | 30. Juni 2026 |
| Compass Wealth Management LLC | $1.766.229 | 0,98% | 26.652 | Aktien | 30. Juni 2026 |
| GOLDMAN SACHS GROUP INC | $1.738.328 | 0,97% | 26.231 | Aktien | 30. Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.391.670 | 0,77% | 21.000 | Kaufoption | 30. Juni 2026 |
| MML INVESTORS SERVICES, LLC | $1.323.563 | 0,74% | 19.972 | Aktien | 30. Juni 2026 |
| ROYAL BANK OF CANADA | $1.265.000 | 0,70% | 19.084 | Aktien | 30. Juni 2026 |
| Rockefeller Capital Management L.P. | $1.250.116 | 0,69% | 18.863 | Aktien | 30. Juni 2026 |
| BLAIR WILLIAM & CO/IL | $1.097.181 | 0,61% | 16.556 | Aktien | 30. Juni 2026 |
| J. Goldman & Co LP | $1.073.574 | 0,60% | 16.200 | Verkaufsoption | 30. Juni 2026 |
| Arax Advisory Partners | $1.005.925 | 0,56% | 15.179 | Aktien | 30. Juni 2026 |
| JANE STREET GROUP, LLC | $974.169 | 0,54% | 14.700 | Verkaufsoption | 30. Juni 2026 |
| Avior Wealth Management, LLC | $799.893 | 0,44% | 12.070 | Aktien | 30. Juni 2026 |
| SummitTX Capital, L.P. | $778.341 | 0,43% | 11.745 | Aktien | 30. Juni 2026 |
| U.S. Capital Wealth Advisors, LLC | $764.463 | 0,42% | 14.133 | Aktien | 31. März 2026 |
| D. E. Shaw & Co., Inc. | $756.538 | 0,42% | 11.416 | Aktien | 30. Juni 2026 |
| STIFEL FINANCIAL CORP | $748.663 | 0,42% | 11.297 | Aktien | 30. Juni 2026 |
| Fragasso Financial Advisors Inc | $443.964 | 0,25% | 6.699 | Aktien | 30. Juni 2026 |
| JANE STREET GROUP, LLC | $414.386 | 0,23% | 6.253 | Aktien | 30. Juni 2026 |
| Sigma Planning Corp | $403.480 | 0,22% | 6.088 | Aktien | 30. Juni 2026 |
| PNC Financial Services Group, Inc. | $390.595 | 0,22% | 5.894 | Aktien | 30. Juni 2026 |
| Beacon Pointe Advisors, LLC | $379.777 | 0,21% | 5.731 | Aktien | 30. Juni 2026 |
| PRINCIPAL SECURITIES, INC. | $372.401 | 0,21% | 5.619 | Aktien | 30. Juni 2026 |
| Ameritas Advisory Services, LLC | $327.290 | 0,18% | 4.939 | Aktien | 30. Juni 2026 |
| INDEPENDENT FINANCIAL GROUP, LLC | $311.469 | 0,17% | 4.700 | Aktien | 30. Juni 2026 |
| OSAIC HOLDINGS, INC. | $306.766 | 0,17% | 4.628 | Aktien | 30. Juni 2026 |
| RAYMOND JAMES FINANCIAL INC | $269.378 | 0,15% | 4.065 | Aktien | 30. Juni 2026 |
| NewEdge Wealth, LLC | $267.267 | 0,15% | 4.033 | Aktien | 30. Juni 2026 |
| VISTA INVESTMENT MANAGEMENT | $264.152 | 0,15% | 3.986 | Aktien | 30. Juni 2026 |
| Farther Finance Advisors, LLC | $263.116 | 0,15% | 3.970 | Aktien | 30. Juni 2026 |
| FMR LLC | $251.698 | 0,14% | 3.798 | Aktien | 30. Juni 2026 |
| Lifeworks Advisors, LLC | $251.415 | 0,14% | 3.794 | Aktien | 30. Juni 2026 |
| Kestra Advisory Services, LLC | $248.983 | 0,14% | 3.757 | Aktien | 30. Juni 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $248.680 | 0,14% | 3.753 | Aktien | 30. Juni 2026 |
| Evelyn Partners Investment Management (Europe) Ltd | $229.883 | 0,13% | 4.250 | Aktien | 31. März 2026 |
| Corient Private Wealth LP | $225.385 | 0,13% | 3.401 | Aktien | 30. Juni 2026 |
| HighTower Advisors, LLC | $219.223 | 0,12% | 3.308 | Aktien | 30. Juni 2026 |
| Belvedere Trading LLC | $218.890 | 0,12% | 3.303 | Aktien | 30. Juni 2026 |
| Focus Partners Wealth | $216.771 | 0,12% | 3.271 | Aktien | 30. Juni 2026 |
| Advantage Trust Co | $215.378 | 0,12% | 3.250 | Aktien | 30. Juni 2026 |
| NATIONAL BANK OF CANADA /FI/ | $160.947 | 0,09% | 2.425 | Aktien | 30. Juni 2026 |
| JONES FINANCIAL COMPANIES LLLP | $152.159 | 0,08% | 2.308 | Aktien | 30. Juni 2026 |
| EP Wealth Advisors, LLC | $151.096 | 0,08% | 2.280 | Aktien | 30. Juni 2026 |
| CIBC Private Wealth Group LLC | $134.520 | 0,07% | 2.806 | Aktien | 30. September 2025 |
| Integrated Wealth Concepts LLC | $132.608 | 0,07% | 2.002 | Aktien | 30. Juni 2026 |
| LANARK FINANCIAL, INC. | $103.198 | 0,06% | 1.557 | Aktien | 30. Juni 2026 |
| BlackRock, Inc. | $99.405 | 0,06% | 1.500 | Aktien | 30. Juni 2026 |
| BANK OF MONTREAL /CAN/ | $92.778 | 0,05% | 1.400 | Aktien | 30. Juni 2026 |
| Institute for Wealth Management, LLC. | $85.953 | 0,05% | 1.297 | Aktien | 30. Juni 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $78.861 | 0,04% | 1.190 | Aktien | 30. Juni 2026 |
| Allworth Financial LP | $52.354 | 0,03% | 790 | Aktien | 30. Juni 2026 |
| WHITTIER TRUST CO | $41.646 | 0,02% | 619 | Aktien | 30. Juni 2026 |
| COMERICA BANK | $33.270 | 0,02% | 594 | Aktien | 31. Dezember 2025 |
| Caitlin John, LLC | $33.135 | 0,02% | 500 | Aktien | 30. Juni 2026 |
| AE Wealth Management LLC | $29.933 | 0,02% | 452 | Aktien | 30. Juni 2026 |
| FIFTH THIRD BANCORP | $29.822 | 0,02% | 450 | Aktien | 30. Juni 2026 |
| Federation des caisses Desjardins du Quebec | $26.508 | 0,01% | 400 | Aktien | 30. Juni 2026 |
| BARCLAYS PLC | $22.797 | 0,01% | 344 | Aktien | 30. Juni 2026 |
| New Republic Capital, LLC | $22.399 | 0,01% | 338 | Aktien | 30. Juni 2026 |
| Ashton Thomas Private Wealth, LLC | $21.604 | 0,01% | 326 | Aktien | 30. Juni 2026 |
| Lindbrook Capital, LLC | $17.301 | 0,01% | 395 | Aktien | 31. März 2025 |
| Qube Research & Technologies Ltd | $15.242 | 0,01% | 230 | Aktien | 30. Juni 2026 |
| Addison Advisors LLC | $12.459 | 0,01% | 188 | Aktien | 30. Juni 2026 |
| Cape Investment Advisory, Inc. | $11.929 | 0,01% | 180 | Aktien | 30. Juni 2026 |
| Steward Partners Investment Advisory, LLC | $11.862 | 0,01% | 179 | Aktien | 30. Juni 2026 |
| Medallion Wealth Advisors, LLC | $9.941 | 0,01% | 150 | Aktien | 30. Juni 2026 |
| ASSETMARK, INC | $8.284 | 0,00% | 125 | Aktien | 30. Juni 2026 |
| IFG Advisory, LLC | $8.004 | 0,00% | 121 | Aktien | 30. Juni 2026 |
| IFP Advisors, Inc | $7.091 | 0,00% | 107 | Aktien | 30. Juni 2026 |
| Global Retirement Partners, LLC | $6.815 | 0,00% | 103 | Aktien | 30. Juni 2026 |
| HUNTINGTON NATIONAL BANK | $6.693 | 0,00% | 101 | Aktien | 30. Juni 2026 |
| First Bancorp, Inc /ME/ | $6.627 | 0,00% | 100 | Aktien | 30. Juni 2026 |
| JPMORGAN CHASE & CO | $5.313 | 0,00% | 80 | Aktien | 30. Juni 2026 |
| CoreCap Advisors, LLC | $2.717 | 0,00% | 41 | Aktien | 30. Juni 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | $2.187 | 0,00% | 33 | Aktien | 30. Juni 2026 |
| Jackson Hole Capital Partners, LLC | $1.893 | 0,00% | 35 | Aktien | 31. März 2026 |
| Front Row Advisors LLC | $1.261 | 0,00% | 18 | Aktien | 30. Juni 2026 |
| Signature Equity Partners, LLC | $1.259 | 0,00% | 19 | Aktien | 30. Juni 2026 |
| PARK AVENUE SECURITIES LLC | $591 | 0,00% | 8.917 | Aktien | 30. Juni 2026 |
| HRT FINANCIAL LP | $553 | 0,00% | 8.348 | Aktien | 30. Juni 2026 |
| CX Institutional | $545 | 0,00% | 8.217 | Aktien | 30. Juni 2026 |
Vergleichsfonds
Mehr von diesem Emittenten
| Fonds | AuM |
|---|---|
| ALLW SSGA Active Trust | $1.3B |
| PRIV SSGA Active Trust | $829.7M |
| MYCH SSGA Active Trust | $555.9M |
| PRSD SSGA Active Trust | $104.0M |
| HECO SSGA Active Trust | $81.7M |
| MYCF SSGA Active Trust | $46.4M |
| MYCJ SSGA Active Trust | $39.6M |
| MYCI SSGA Active Trust | $34.7M |
| MYCG SSGA Active Trust | $30.0M |
| MYCK SSGA Active Trust | $18.6M |
Ähnlich in der Größe
| Fonds | AuM |
|---|---|
| ACLC AMERICAN CENTURY ETF TRUST | $307.9M |
| IGHG ProShares Trust | $309.1M |
| CARK Advisors' Inner Circle Fund II | $309.3M |
| BUFG First Trust Exchange-Traded Fun… | $312.3M |
| USDX RBB Fund, Inc. | $312.6M |
| CPLB New York Life Investments Activ… | $307.5M |
| JXI iShares Trust | $307.4M |
| DECU AIM ETF Products Trust | $307.3M |
| GOCT First Trust Exchange-Traded Fun… | $306.8M |
| PFFV Global X Funds | $306.3M |